Search

Your search keyword '"Boris Kallmann"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Boris Kallmann" Remove constraint Author: "Boris Kallmann"
19 results on '"Boris Kallmann"'

Search Results

1. REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program

2. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

3. An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM)

4. Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)

5. Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4

6. Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose

7. Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status

8. Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion

9. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

10. An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM)

11. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

12. Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod : a multi-center observational study

13. Bedeutung regionaler Netzwerke bei der Versorgung von MS-Patienten

14. Long-term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials

15. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis

16. UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum

17. Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

18. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis

19. Inflammation in multiple sclerosis: the good, the bad, and the complex

Catalog

Books, media, physical & digital resources